Literature DB >> 10967284

Dengue viral infections; pathogenesis and epidemiology.

W J McBride1, H Bielefeldt-Ohmann.   

Abstract

Dengue viral infections affect up to 100 million individuals per year. Dengue haemorrhagic fever is a clinical form of disease characterised by intravascular fluid loss. There has been a marked increase in the incidence of this form of the disease over the last few decades, associated with significant mortality, particularly in the paediatric population. A number of theories relating to the pathogenesis of dengue haemorrhagic fever exist that have evolved from the analysis of the epidemiology of this disease. Virological and immunopathological factors are both important but the exact mechanisms for the disease are unknown.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10967284     DOI: 10.1016/s1286-4579(00)01258-2

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  43 in total

1.  Genetic characterization of newly reintroduced dengue virus type 3 in Martinique (French West Indies).

Authors:  Christophe N Peyrefitte; Patricia Couissinier-Paris; Véronique Mercier-Perennec; Maël Bessaud; Jenny Martial; Nadia Kenane; Jean-Paul A Durand; Hugues J Tolou
Journal:  J Clin Microbiol       Date:  2003-11       Impact factor: 5.948

Review 2.  Dengue: an escalating problem.

Authors:  Robert V Gibbons; David W Vaughn
Journal:  BMJ       Date:  2002-06-29

3.  Inhibition of flavivirus infections by antisense oligomers specifically suppressing viral translation and RNA replication.

Authors:  Tia S Deas; Iwona Binduga-Gajewska; Mark Tilgner; Ping Ren; David A Stein; Hong M Moulton; Patrick L Iversen; Elizabeth B Kauffman; Laura D Kramer; Pei-Yong Shi
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

Review 4.  Virus interactions with endothelial cell receptors: implications for viral pathogenesis.

Authors:  Nadine A Dalrymple; Erich R Mackow
Journal:  Curr Opin Virol       Date:  2014-07-24       Impact factor: 7.090

5.  Productive dengue virus infection of human endothelial cells is directed by heparan sulfate-containing proteoglycan receptors.

Authors:  Nadine Dalrymple; Erich R Mackow
Journal:  J Virol       Date:  2011-07-06       Impact factor: 5.103

6.  Enzyme-linked immunosorbent assay specific to Dengue virus type 1 nonstructural protein NS1 reveals circulation of the antigen in the blood during the acute phase of disease in patients experiencing primary or secondary infections.

Authors:  Sophie Alcon; Antoine Talarmin; Monique Debruyne; Andrew Falconar; Vincent Deubel; Marie Flamand
Journal:  J Clin Microbiol       Date:  2002-02       Impact factor: 5.948

7.  CD8 T cell-initiated vascular endothelial growth factor expression promotes central nervous system vascular permeability under neuroinflammatory conditions.

Authors:  Georgette L Suidan; Jonathan W Dickerson; Yi Chen; Jeremiah R McDole; Pulak Tripathi; Istvan Pirko; Kim B Seroogy; Aaron J Johnson
Journal:  J Immunol       Date:  2009-12-11       Impact factor: 5.422

8.  Safety and efficacy of chimeric yellow Fever-dengue virus tetravalent vaccine formulations in nonhuman primates.

Authors:  F Guirakhoo; K Pugachev; Z Zhang; G Myers; I Levenbook; K Draper; J Lang; S Ocran; F Mitchell; M Parsons; N Brown; S Brandler; C Fournier; B Barrere; F Rizvi; A Travassos; R Nichols; D Trent; T Monath
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

9.  2nd International external quality control assessment for the molecular diagnosis of dengue infections.

Authors:  Cristina Domingo; Matthias Niedrig; Anette Teichmann; Marco Kaiser; Leonid Rumer; Richard G Jarman; Oliver Donoso-Mantke
Journal:  PLoS Negl Trop Dis       Date:  2010-10-05

10.  Phylogenetic history demonstrates two different lineages of dengue type 1 virus in Colombia.

Authors:  Jairo A Mendez; Jose A Usme-Ciro; Cristina Domingo; Gloria J Rey; Juan A Sanchez; Antonio Tenorio; Juan C Gallego-Gomez
Journal:  Virol J       Date:  2010-09-14       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.